Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch... see more

TSX:SVA - Post Discussion

Sernova Corp > Wake up Sleepy Spill.
View:
Post by BioTeck on Dec 05, 2022 1:15pm

Wake up Sleepy Spill.

Hemo ship has sailed and so has thyroid. Just a matter of time before the diabetes ship leaves too. So much time wasted, sad. Went from bleeding edge to the laggard in the industry.




https://www.ctvnews.ca/health/canadian-patient-receives-groundbreaking-treatment-for-a-disabling-disorder-with-a-parathyroid-transplant-into-her-arm-1.6160013?cid=sm%3Atrueanthem%3Actvnews%3Apost&utm_campaign=trueAnthem%3A%20New%20Content%20(Feed)&utm_medium=trueAnthem&utm_source=facebook&fbclid=IwAR1VhkPeGhfeHvctKzyjDR-pVIu5mM0HLlsXmxtEu6viF9plNOPRL_ps41w
Comment by Metalsguy1 on Dec 05, 2022 5:05pm
I wouldn't call it a wash on thyroid just yet. The pouch would still be a better home than just transplanting to the forearm. The conformal coating would eliminate the need for drugs. Hemophilia B approved treatment on the other hand points to the likelihood that A is not far behind so hemophilia is most assuredly a dead end for the pouch unless they come in way less than 3.5 million for ...more  
Comment by BioTeck on Dec 05, 2022 8:59pm
They got approval to do this in humans without any device. Fill is still stuck philling out the application with Health Canada for 5 years.  Conformal coating, if works, would be worth more than total Sernova. Wonder why they'd give away such a valuable technology for a mere million dollars...
Comment by MustangSalley on Dec 05, 2022 9:16pm
Turtle Toleikis , The pace he's on, there will be no indications left at all but Alzheimer's.  Funny how the share price is manipulated up and down by participants of bought deal.  After that , nothing has been advanced . Does the comfy couch come with a recliner ? Bet it does because for Sleepy Phil.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities